Psychedelic Clinical Trials
Find clinical trials studying psilocybin, MDMA, ketamine and other psychedelics. Many trials are actively recruiting participants who haven't found relief from conventional treatments.
PEX010-Assisted Therapy for Stimulant Use Disorder: A Safety, Feasibility and Efficacy Study
Filament Health Corp.
Disease Modifying Therapies Withdrawal in Inactive Relapsing-remitting Multiple Sclerosis Patients Aged 55 and Over (TWINS : Therapies Withdrawal IN Relapsing Multiple Sclerosis)
University Hospital, Strasbourg, France
Acupressure's Impact on Pain and Physiological Parameters in Infants Undergoing Cardiac Catheterization
Baskent University
Opioid Free Anesthesia Versus Opioid Based Anesthesia
Ain Shams University
The Effects of Psilocybin on Shared Experience in Film Processing
Western University, Canada
Axitinib and Oral Metronomic Etoposide for Pediatric Children and AYA Refractory/Relapsing Medulloblastoma and Ependymoma
Assistance Publique Hopitaux De Marseille
Psilocybin-assisted Therapy for Alcohol Use Disorder
University of Sydney
Effect of Opioid-free Anesthesia on Sleep Quality, Cognitive Function and Recovery Quality After General Anesthesia in Elderly Patients
Beijing Friendship Hospital
Effects of Minimal-Flow Sevoflurane and Multimodal Analgesia in Head and Neck Cancer Surgery
National Taiwan University Hospital
Quelling of Excitotoxicity in Acute Stroke With Ketamine
Lower Merion Neurology Research Foundation
Ketamine Treatment for PTSD and MDD in TBI
Minneapolis Veterans Affairs Medical Center
Mindfulness-based Psilocybin Therapy for PTSD
Anthony P King
MDMA-Assisted Massed Exposure Therapy for PTSD
Emory University
Ketamine in Severe Traumatic Brain Injury
University of Texas Southwestern Medical Center
A Study of Psychedelics in Healthy Older Adults With Low Well-being
Jennifer Mitchell
Group Retreat Psilocybin Therapy for the Treatment of Anxiety and Depression in Patients With Metastatic Solid Tumors or Incurable Hematologic Malignancies
University of Washington
MDMA-Assisted Therapy for Veterans With PTSD and Alcohol Use Disorder
VA Office of Research and Development
Psilocybin Whole Mushroom for the Treatment of Obsessive-compulsive Disorder.
Francisco A Moreno
Subjective Experience Following Psilocybin
University of Calgary
Subanesthetic Ketamine Infusions for Depressive Symptoms in Intensive Care Unit Patients
Hospital Italiano de Buenos Aires
A Phase 3 Trial of DT120 for Major Depressive Disorder (Ascend)
Definium Therapeutics US, Inc.
An International Federated Model for Wearable-derived Remote Longitudinal Motor Monitoring in Young Children With Spinal Muscular Atrophy Compared With Healthy Controls: Active-NBS Study (UK)
University of Oxford
Psilocybin to Treat Depression in Spinal Cord Injury
James J. Peters Veterans Affairs Medical Center
Group Psilocybin-Assisted Therapy for Post-Traumatic Stress Disorder
University of New Mexico
Study of Midomafetamine in Healthy Adults
Resilient Pharmaceuticals
Safety, Therapeutic Potential, and Mechanisms of Two Psilocybin Doses, Administered With Psychological Support in Young Adults With Anorexia Nervosa
Region Skane
Induction Agent Choice With Early Mortality and Prognostic Outcomes in Critically Ill Patients
Zeliha Alicikus
Ketamine and Propofol NeuroImaging
Keith M Vogt
Sub-dissociative Dose Ketamine in Treatment of Vaso-occlusive Pain Event in Children and Young Adults
Mohsen Saidinejad
MDMA-assisted Therapy for Fibromyalgia
Spaulding Rehabilitation Hospital
Safety and Efficacy of Psilocybin-assisted Psychotherapy for Demoralization Syndrome in Patients Diagnosed With Advanced Stage Cancer
Gustavo Vazquez
Safety and Tolerability Trial of Psilocybin in Healthy Older Adults
University of Colorado, Denver
Pilot Study: Establishing Glutamatergic Changes in Rapid Antidepressant Effects of Ketamine
University of Pennsylvania
Psilocybin-Assisted Therapy for Sexual Assault-Related PTSD
Sunstone Medical
Coaching as an Adjunct to Ketamine Therapy for Treatment-Resistant Depression
Massachusetts General Hospital
Acute Effects of Intravenous 5-MeO-DMT in Healthy Participants
University Hospital, Basel, Switzerland
ATLAS-1: Advanced Trial for Longitudinal Assessment in Salma 1
Salma Health, Inc.
Acute Analgesic Effects of MDMA on Experimentally Induced Acute Pain, Hyperalgesia and Allodynia in Healthy Participants
University Hospital, Basel, Switzerland
Ketamine add-on Therapy for Established Status Epilepticus Treatment Trial (KESETT)
University of Virginia
Pharmacokinetics of Didehydro-LSD (DDH-LSD) Compared With LSD
University Hospital, Basel, Switzerland
Prospective IR-led Sedation Feasibility
CAMC Health System
Ketamine for Veterans With Parkinson's Disease
VA Office of Research and Development
Psilocybin for Prolonged Grief Disorder
University of Virginia
MDMA-Assisted Therapy for Mental Healthcare Providers
Rachel Yehuda
Psychedelic Healing: Adjunct Therapy Harnessing Opened Malleability
Johns Hopkins University
Safety and Preliminary Efficacy of Organic Whole Psilocybin-Containing Mushrooms to Treat Patients Suffering From PTSD
Suzanne "Sue" Sisley MD
Ketamine for Opioid Use Disorder
University of Maryland, Baltimore
Ecstasy to Alleviate SEvere Chronic Neuropathic Pain Trial
Unity Health Toronto
Browse by Condition
View all conditions →How to Join a Clinical Trial
Clinical trials are research studies that test new treatments. Participating can give you access to cutting-edge therapies while contributing to medical science. Each trial has specific eligibility criteria based on the research goals.
1. Review
Read the trial details, eligibility criteria, and what participation involves.
2. Contact
Reach out to the study team using the contact information provided.
3. Screen
Complete the screening process to determine if you're eligible.